nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—SLC22A3—Vincristine—muscle cancer	0.507	0.806	CbGbCtD
Phenoxybenzamine—CYP3A4—Vincristine—muscle cancer	0.0479	0.0761	CbGbCtD
Phenoxybenzamine—CYP3A4—Etoposide—muscle cancer	0.0439	0.0698	CbGbCtD
Phenoxybenzamine—CYP3A4—Doxorubicin—muscle cancer	0.0299	0.0476	CbGbCtD
Phenoxybenzamine—SLC22A2—renal system—muscle cancer	0.00524	0.0381	CbGeAlD
Phenoxybenzamine—ADRA1B—renal system—muscle cancer	0.00502	0.0365	CbGeAlD
Phenoxybenzamine—SLC22A3—embryo—muscle cancer	0.00468	0.034	CbGeAlD
Phenoxybenzamine—CALM3—smooth muscle tissue—muscle cancer	0.00398	0.0289	CbGeAlD
Phenoxybenzamine—CALM2—embryo—muscle cancer	0.00397	0.0289	CbGeAlD
Phenoxybenzamine—CALM1—embryo—muscle cancer	0.00395	0.0288	CbGeAlD
Phenoxybenzamine—SLC22A1—renal system—muscle cancer	0.0037	0.0269	CbGeAlD
Phenoxybenzamine—SLC22A3—smooth muscle tissue—muscle cancer	0.00368	0.0268	CbGeAlD
Phenoxybenzamine—SLC22A3—renal system—muscle cancer	0.00354	0.0258	CbGeAlD
Phenoxybenzamine—CALM3—cardiac atrium—muscle cancer	0.00343	0.0249	CbGeAlD
Phenoxybenzamine—ADRA1B—head—muscle cancer	0.00336	0.0244	CbGeAlD
Phenoxybenzamine—ADRA1D—head—muscle cancer	0.00329	0.0239	CbGeAlD
Phenoxybenzamine—CALM2—smooth muscle tissue—muscle cancer	0.00312	0.0227	CbGeAlD
Phenoxybenzamine—CALM1—smooth muscle tissue—muscle cancer	0.00311	0.0226	CbGeAlD
Phenoxybenzamine—CALM2—renal system—muscle cancer	0.00301	0.0219	CbGeAlD
Phenoxybenzamine—CALM1—renal system—muscle cancer	0.00299	0.0218	CbGeAlD
Phenoxybenzamine—CALM3—tendon—muscle cancer	0.00299	0.0217	CbGeAlD
Phenoxybenzamine—CALM3—bone marrow—muscle cancer	0.0029	0.0211	CbGeAlD
Phenoxybenzamine—ADRA1A—renal system—muscle cancer	0.00282	0.0205	CbGeAlD
Phenoxybenzamine—CALM3—vagina—muscle cancer	0.00277	0.0202	CbGeAlD
Phenoxybenzamine—CALM2—cardiac atrium—muscle cancer	0.00269	0.0196	CbGeAlD
Phenoxybenzamine—ADRA2C—renal system—muscle cancer	0.00269	0.0196	CbGeAlD
Phenoxybenzamine—SLC22A1—vagina—muscle cancer	0.00268	0.0195	CbGeAlD
Phenoxybenzamine—CALM1—cardiac atrium—muscle cancer	0.00268	0.0195	CbGeAlD
Phenoxybenzamine—SLC22A3—vagina—muscle cancer	0.00256	0.0187	CbGeAlD
Phenoxybenzamine—SLC22A1—head—muscle cancer	0.00248	0.018	CbGeAlD
Phenoxybenzamine—CALM3—testis—muscle cancer	0.00248	0.018	CbGeAlD
Phenoxybenzamine—ADRA2C—cardiac atrium—muscle cancer	0.00241	0.0175	CbGeAlD
Phenoxybenzamine—SLC22A3—head—muscle cancer	0.00237	0.0172	CbGeAlD
Phenoxybenzamine—CALM2—tendon—muscle cancer	0.00235	0.0171	CbGeAlD
Phenoxybenzamine—CALM1—tendon—muscle cancer	0.00234	0.017	CbGeAlD
Phenoxybenzamine—SLC22A3—testis—muscle cancer	0.00229	0.0166	CbGeAlD
Phenoxybenzamine—CALM2—bone marrow—muscle cancer	0.00227	0.0165	CbGeAlD
Phenoxybenzamine—CALM1—bone marrow—muscle cancer	0.00226	0.0165	CbGeAlD
Phenoxybenzamine—CALM2—vagina—muscle cancer	0.00218	0.0158	CbGeAlD
Phenoxybenzamine—CALM1—vagina—muscle cancer	0.00217	0.0158	CbGeAlD
Phenoxybenzamine—ADRA2C—tendon—muscle cancer	0.0021	0.0153	CbGeAlD
Phenoxybenzamine—CALM2—head—muscle cancer	0.00201	0.0146	CbGeAlD
Phenoxybenzamine—CALM1—head—muscle cancer	0.002	0.0146	CbGeAlD
Phenoxybenzamine—ADRA2C—vagina—muscle cancer	0.00195	0.0142	CbGeAlD
Phenoxybenzamine—CALM2—testis—muscle cancer	0.00194	0.0141	CbGeAlD
Phenoxybenzamine—CALM1—testis—muscle cancer	0.00193	0.0141	CbGeAlD
Phenoxybenzamine—ADRA2A—cardiac atrium—muscle cancer	0.00192	0.014	CbGeAlD
Phenoxybenzamine—ADRA1A—head—muscle cancer	0.00189	0.0137	CbGeAlD
Phenoxybenzamine—ADRA2C—head—muscle cancer	0.0018	0.0131	CbGeAlD
Phenoxybenzamine—ADRA2C—testis—muscle cancer	0.00174	0.0126	CbGeAlD
Phenoxybenzamine—CYP3A4—renal system—muscle cancer	0.00169	0.0123	CbGeAlD
Phenoxybenzamine—ADRA2A—tendon—muscle cancer	0.00167	0.0122	CbGeAlD
Phenoxybenzamine—ADRA2A—vagina—muscle cancer	0.00155	0.0113	CbGeAlD
Phenoxybenzamine—ADRA2A—head—muscle cancer	0.00143	0.0104	CbGeAlD
Phenoxybenzamine—ADRA2A—testis—muscle cancer	0.00139	0.0101	CbGeAlD
Phenoxybenzamine—CALM1—Signaling by EGFR in Cancer—MDM2—muscle cancer	0.000244	0.00104	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by PDGF—MDM2—muscle cancer	0.000243	0.00104	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by PDGF—MDM2—muscle cancer	0.000243	0.00104	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KIDINS220—muscle cancer	0.000242	0.00104	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KIDINS220—muscle cancer	0.000242	0.00104	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—FH—muscle cancer	0.000241	0.00103	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—PTCH1—muscle cancer	0.000241	0.00103	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—PTCH1—muscle cancer	0.000238	0.00102	CbGpPWpGaD
Phenoxybenzamine—CALM3—B Cell Activation—MDM2—muscle cancer	0.000238	0.00102	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000236	0.00101	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—FH—muscle cancer	0.000233	0.001	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—FH—muscle cancer	0.000233	0.001	CbGpPWpGaD
Phenoxybenzamine—CALM3—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000233	0.000997	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Neuronal System—MDM2—muscle cancer	0.000231	0.000987	CbGpPWpGaD
Phenoxybenzamine—CALM2—B Cell Activation—MDM2—muscle cancer	0.00023	0.000984	CbGpPWpGaD
Phenoxybenzamine—CALM1—B Cell Activation—MDM2—muscle cancer	0.00023	0.000984	CbGpPWpGaD
Phenoxybenzamine—CALM3—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.000227	0.000973	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—CNR1—muscle cancer	0.000225	0.000965	CbGpPWpGaD
Phenoxybenzamine—CALM1—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000225	0.000964	CbGpPWpGaD
Phenoxybenzamine—CALM2—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000225	0.000964	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—PTCH1—muscle cancer	0.000225	0.000964	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—FOXO4—muscle cancer	0.000225	0.000964	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—CNR1—muscle cancer	0.000224	0.000959	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—KIT—muscle cancer	0.000222	0.000951	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—PTCH1—muscle cancer	0.000222	0.000949	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—CNR1—muscle cancer	0.000221	0.000947	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.00022	0.000943	CbGpPWpGaD
Phenoxybenzamine—CALM1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.00022	0.000942	CbGpPWpGaD
Phenoxybenzamine—CALM2—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	0.00022	0.000942	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—IGF2—muscle cancer	0.00022	0.000941	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—FOXO4—muscle cancer	0.000218	0.000932	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—FOXO4—muscle cancer	0.000218	0.000932	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—FOXO4—muscle cancer	0.000216	0.000925	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—KIT—muscle cancer	0.000215	0.00092	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—KIT—muscle cancer	0.000215	0.00092	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—CNR1—muscle cancer	0.000209	0.000896	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—FOXO4—muscle cancer	0.000209	0.000895	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—FOXO4—muscle cancer	0.000209	0.000895	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—CNR1—muscle cancer	0.000206	0.000882	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—CNR1—muscle cancer	0.000203	0.000871	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—CNR1—muscle cancer	0.000201	0.00086	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—IGF2—muscle cancer	0.000201	0.000859	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—PTCH1—muscle cancer	0.000197	0.000843	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—IGF2—muscle cancer	0.000194	0.000831	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—IGF2—muscle cancer	0.000194	0.000831	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD34—muscle cancer	0.000193	0.000826	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—CNR1—muscle cancer	0.00019	0.000814	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—MED12—muscle cancer	0.000189	0.00081	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—CNR1—muscle cancer	0.000187	0.000801	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD34—muscle cancer	0.000187	0.000799	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD34—muscle cancer	0.000187	0.000799	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—MED12—muscle cancer	0.000184	0.000788	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—CNR1—muscle cancer	0.000183	0.000783	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—PTCH1—muscle cancer	0.000183	0.000783	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000179	0.000766	CbGpPWpGaD
Phenoxybenzamine—CALM3—Neuronal System—MDM2—muscle cancer	0.000178	0.000764	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—MED12—muscle cancer	0.000176	0.000755	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—MDM2—muscle cancer	0.000175	0.000749	CbGpPWpGaD
Phenoxybenzamine—CALM1—Neuronal System—MDM2—muscle cancer	0.000173	0.000739	CbGpPWpGaD
Phenoxybenzamine—CALM2—Neuronal System—MDM2—muscle cancer	0.000173	0.000739	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—ENO2—muscle cancer	0.000172	0.000738	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—CNR1—muscle cancer	0.00017	0.000728	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—MDM2—muscle cancer	0.000169	0.000724	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—MDM2—muscle cancer	0.000169	0.000724	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—ENO2—muscle cancer	0.000168	0.000718	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—PTCH1—muscle cancer	0.000167	0.000714	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—FOXO1—muscle cancer	0.000166	0.000712	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CNR1—muscle cancer	0.000166	0.000711	CbGpPWpGaD
Phenoxybenzamine—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000163	0.000699	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—PTCH1—muscle cancer	0.000161	0.000691	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—PTCH1—muscle cancer	0.000161	0.000691	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—FOXO1—muscle cancer	0.000161	0.000688	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—FOXO1—muscle cancer	0.000161	0.000688	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—ENO2—muscle cancer	0.000161	0.000688	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—FOXO1—muscle cancer	0.00016	0.000683	CbGpPWpGaD
Phenoxybenzamine—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000158	0.000676	CbGpPWpGaD
Phenoxybenzamine—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000158	0.000676	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PTCH1—muscle cancer	0.000158	0.000675	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—FOXO1—muscle cancer	0.000154	0.000661	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—FOXO1—muscle cancer	0.000154	0.000661	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CNR1—muscle cancer	0.000154	0.000661	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—MED12—muscle cancer	0.000149	0.00064	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—ENO2—muscle cancer	0.000148	0.000636	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—ENO2—muscle cancer	0.000144	0.000615	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—ENO2—muscle cancer	0.000144	0.000615	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PTCH1—muscle cancer	0.000142	0.00061	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CNR1—muscle cancer	0.000141	0.000603	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PTCH1—muscle cancer	0.000141	0.000602	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—MED12—muscle cancer	0.000136	0.000584	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ENO2—muscle cancer	0.000136	0.000583	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CNR1—muscle cancer	0.000136	0.000583	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CNR1—muscle cancer	0.000136	0.000583	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—FOXO4—muscle cancer	0.000136	0.000581	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HMGA1—muscle cancer	0.000135	0.000578	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CNR1—muscle cancer	0.000133	0.00057	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PTCH1—muscle cancer	0.000133	0.000569	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—MED12—muscle cancer	0.000132	0.000565	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—MED12—muscle cancer	0.000132	0.000565	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—FOXO4—muscle cancer	0.000131	0.000561	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PTCH1—muscle cancer	0.000131	0.00056	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HMGA1—muscle cancer	0.000131	0.000559	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HMGA1—muscle cancer	0.000131	0.000559	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—FOXO4—muscle cancer	0.000127	0.000543	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—FOXO4—muscle cancer	0.000127	0.000543	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—KIT—muscle cancer	0.000127	0.000542	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ENO2—muscle cancer	0.000124	0.000532	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—KIT—muscle cancer	0.000123	0.000525	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—KIT—muscle cancer	0.000123	0.000525	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—FOXO4—muscle cancer	0.000122	0.000524	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—KIT—muscle cancer	0.000122	0.000521	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—VEGFA—muscle cancer	0.000122	0.00052	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—FOXO4—muscle cancer	0.000121	0.000518	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—FOXO4—muscle cancer	0.000121	0.000517	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ENO2—muscle cancer	0.00012	0.000515	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ENO2—muscle cancer	0.00012	0.000515	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CNR1—muscle cancer	0.00012	0.000514	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CNR1—muscle cancer	0.000119	0.000508	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—KIT—muscle cancer	0.000118	0.000504	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—KIT—muscle cancer	0.000118	0.000504	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—FOXO4—muscle cancer	0.000117	0.000501	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—FOXO4—muscle cancer	0.000117	0.000501	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTCH1—muscle cancer	0.000116	0.000498	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—FOXO4—muscle cancer	0.000114	0.00049	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—VEGFA—muscle cancer	0.000114	0.000486	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—FH—muscle cancer	0.000113	0.000482	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—FOXO4—muscle cancer	0.000113	0.000482	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CNR1—muscle cancer	0.000112	0.000481	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CNR1—muscle cancer	0.00011	0.000473	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IGF2—muscle cancer	0.000109	0.000466	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTCH1—muscle cancer	0.000108	0.000462	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—FOXO1—muscle cancer	0.0001	0.000429	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—FOXO4—muscle cancer	0.0001	0.000428	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—MDM2—muscle cancer	9.97e-05	0.000427	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTCH1—muscle cancer	9.86e-05	0.000422	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IGF2—muscle cancer	9.82e-05	0.000421	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CNR1—muscle cancer	9.81e-05	0.00042	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IGF2—muscle cancer	9.7e-05	0.000415	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—FOXO1—muscle cancer	9.68e-05	0.000414	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—MDM2—muscle cancer	9.65e-05	0.000413	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—MDM2—muscle cancer	9.65e-05	0.000413	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—PTGS2—muscle cancer	9.58e-05	0.00041	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—MDM2—muscle cancer	9.58e-05	0.00041	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTCH1—muscle cancer	9.53e-05	0.000408	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTCH1—muscle cancer	9.53e-05	0.000408	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—FOXO1—muscle cancer	9.36e-05	0.000401	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—FOXO1—muscle cancer	9.36e-05	0.000401	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—FOXO4—muscle cancer	9.29e-05	0.000398	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—MDM2—muscle cancer	9.27e-05	0.000397	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—MDM2—muscle cancer	9.27e-05	0.000397	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—VEGFA—muscle cancer	9.22e-05	0.000395	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Hemostasis—TP53—muscle cancer	9.18e-05	0.000393	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IGF2—muscle cancer	9.18e-05	0.000393	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CNR1—muscle cancer	9.12e-05	0.00039	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—FOXO1—muscle cancer	9.04e-05	0.000387	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IGF2—muscle cancer	9.03e-05	0.000387	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—FOXO1—muscle cancer	8.94e-05	0.000383	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—FOXO1—muscle cancer	8.93e-05	0.000382	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—FOXO1—muscle cancer	8.65e-05	0.00037	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—FOXO1—muscle cancer	8.65e-05	0.00037	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—TP53—muscle cancer	8.58e-05	0.000367	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FOXO4—muscle cancer	8.47e-05	0.000363	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—FOXO1—muscle cancer	8.45e-05	0.000362	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—VEGFA—muscle cancer	8.41e-05	0.00036	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CNR1—muscle cancer	8.32e-05	0.000356	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—FOXO1—muscle cancer	8.31e-05	0.000356	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FOXO4—muscle cancer	8.2e-05	0.000351	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FOXO4—muscle cancer	8.2e-05	0.000351	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—VEGFA—muscle cancer	8.14e-05	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—VEGFA—muscle cancer	8.14e-05	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CNR1—muscle cancer	8.05e-05	0.000345	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CNR1—muscle cancer	8.05e-05	0.000345	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IGF2—muscle cancer	8.02e-05	0.000343	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—KIT—muscle cancer	7.63e-05	0.000327	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IGF2—muscle cancer	7.45e-05	0.000319	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—FOXO1—muscle cancer	7.38e-05	0.000316	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—KIT—muscle cancer	7.38e-05	0.000316	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KIT—muscle cancer	7.14e-05	0.000306	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KIT—muscle cancer	7.14e-05	0.000306	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—TP53—muscle cancer	6.97e-05	0.000298	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—KIT—muscle cancer	6.89e-05	0.000295	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—FOXO1—muscle cancer	6.86e-05	0.000294	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—KIT—muscle cancer	6.81e-05	0.000292	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—KIT—muscle cancer	6.8e-05	0.000291	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IGF2—muscle cancer	6.8e-05	0.000291	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—KIT—muscle cancer	6.59e-05	0.000282	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—KIT—muscle cancer	6.59e-05	0.000282	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IGF2—muscle cancer	6.58e-05	0.000282	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IGF2—muscle cancer	6.58e-05	0.000282	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—KIT—muscle cancer	6.44e-05	0.000276	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MED12—muscle cancer	6.37e-05	0.000273	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—TP53—muscle cancer	6.36e-05	0.000272	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—KIT—muscle cancer	6.33e-05	0.000271	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—FOXO1—muscle cancer	6.26e-05	0.000268	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—TP53—muscle cancer	6.15e-05	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—TP53—muscle cancer	6.15e-05	0.000263	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—FOXO1—muscle cancer	6.05e-05	0.000259	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—FOXO1—muscle cancer	6.05e-05	0.000259	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—MDM2—muscle cancer	6.01e-05	0.000257	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PTGS2—muscle cancer	6.01e-05	0.000257	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PTGS2—muscle cancer	5.84e-05	0.00025	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—MDM2—muscle cancer	5.81e-05	0.000249	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ENO2—muscle cancer	5.81e-05	0.000249	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KIT—muscle cancer	5.63e-05	0.000241	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—MDM2—muscle cancer	5.62e-05	0.000241	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—MDM2—muscle cancer	5.62e-05	0.000241	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PTGS2—muscle cancer	5.6e-05	0.00024	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—MDM2—muscle cancer	5.43e-05	0.000232	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—MDM2—muscle cancer	5.36e-05	0.00023	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—MDM2—muscle cancer	5.36e-05	0.000229	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KIT—muscle cancer	5.23e-05	0.000224	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MDM2—muscle cancer	5.19e-05	0.000222	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MDM2—muscle cancer	5.19e-05	0.000222	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PTGS2—muscle cancer	5.17e-05	0.000221	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MDM2—muscle cancer	5.07e-05	0.000217	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PTGS2—muscle cancer	5e-05	0.000214	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PTGS2—muscle cancer	5e-05	0.000214	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MDM2—muscle cancer	4.99e-05	0.000214	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KIT—muscle cancer	4.77e-05	0.000204	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PTGS2—muscle cancer	4.75e-05	0.000203	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KIT—muscle cancer	4.61e-05	0.000198	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KIT—muscle cancer	4.61e-05	0.000198	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—VEGFA—muscle cancer	4.56e-05	0.000195	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MDM2—muscle cancer	4.43e-05	0.00019	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PTGS2—muscle cancer	4.33e-05	0.000185	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000179	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTGS2—muscle cancer	4.19e-05	0.000179	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—VEGFA—muscle cancer	4.12e-05	0.000176	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MDM2—muscle cancer	4.12e-05	0.000176	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—VEGFA—muscle cancer	4.07e-05	0.000174	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—VEGFA—muscle cancer	3.85e-05	0.000165	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—VEGFA—muscle cancer	3.79e-05	0.000162	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MDM2—muscle cancer	3.76e-05	0.000161	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MDM2—muscle cancer	3.63e-05	0.000156	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MDM2—muscle cancer	3.63e-05	0.000156	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—muscle cancer	3.45e-05	0.000148	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—muscle cancer	3.36e-05	0.000144	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—muscle cancer	3.13e-05	0.000134	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—muscle cancer	3.11e-05	0.000133	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—muscle cancer	3.07e-05	0.000132	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—muscle cancer	2.91e-05	0.000125	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—muscle cancer	2.86e-05	0.000123	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—muscle cancer	2.85e-05	0.000122	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—muscle cancer	2.76e-05	0.000118	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—muscle cancer	2.76e-05	0.000118	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—muscle cancer	2.54e-05	0.000109	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—muscle cancer	2.36e-05	0.000101	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—muscle cancer	2.16e-05	9.23e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—muscle cancer	2.08e-05	8.93e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—muscle cancer	2.08e-05	8.93e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTGS2—muscle cancer	2.02e-05	8.66e-05	CbGpPWpGaD
